These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18324758)

  • 41. Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors.
    Chin J; Adams AD; Bouffard A; Green A; Lacson RG; Smith T; Fischer PA; Menke JG; Sparrow CP; Mitnaul LJ
    Assay Drug Dev Technol; 2003 Dec; 1(6):777-87. PubMed ID: 15090224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
    Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma.
    Nakaya K; Ayaori M; Hisada T; Sawada S; Tanaka N; Iwamoto N; Ogura M; Yakushiji E; Kusuhara M; Nakamura H; Ohsuzu F
    J Atheroscler Thromb; 2007 Jun; 14(3):133-41. PubMed ID: 17587765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
    Qin Y; Dalen KT; Gustafsson JA; Nebb HI
    Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery and structure-activity relationship studies of indole derivatives as liver X receptor (LXR) agonists.
    Bakir F; Kher S; Pannala M; Wilson N; Nguyen T; Sircar I; Takedomi K; Fukushima C; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Schneider L; Sakurai N; Jack R; Cheng JF
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3473-9. PubMed ID: 17416521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.
    Kher S; Lake K; Sircar I; Pannala M; Bakir F; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Sakurai N; Jack R; Cheng JF
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4442-6. PubMed ID: 17587573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events.
    Svärd J; Blanco F; Nevin D; Fayne D; Mulcahy F; Hennessy M; Spiers JP
    Br J Pharmacol; 2014 Jan; 171(2):480-97. PubMed ID: 24372550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
    Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR
    Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
    Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
    J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and identification of new flavonoids targeting liver X receptor β involved pathway as potential facilitators of Aβ clearance with reduced lipid accumulation.
    Hu Y; Yang Y; Yu Y; Wen G; Shang N; Zhuang W; Lu D; Zhou B; Liang B; Yue X; Li F; Du J; Bu X
    J Med Chem; 2013 Aug; 56(15):6033-53. PubMed ID: 23844653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
    Ou X; Dai X; Long Z; Tang Y; Cao D; Hao X; Hu Y; Li X; Tang C
    Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery and optimization of a novel series of liver X receptor-alpha agonists.
    Li L; Liu J; Zhu L; Cutler S; Hasegawa H; Shan B; Medina JC
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1638-42. PubMed ID: 16386417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.
    Bennett DJ; Cooke AJ; Edwards AS
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):21-46. PubMed ID: 18221072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
    Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthetic LXR agonists increase LDL in CETP species.
    Groot PH; Pearce NJ; Yates JW; Stocker C; Sauermelch C; Doe CP; Willette RN; Olzinski A; Peters T; d'Epagnier D; Morasco KO; Krawiec JA; Webb CL; Aravindhan K; Jucker B; Burgert M; Ma C; Marino JP; Collins JL; Macphee CH; Thompson SK; Jaye M
    J Lipid Res; 2005 Oct; 46(10):2182-91. PubMed ID: 16024916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
    Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
    Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.
    Molteni V; Li X; Nabakka J; Liang F; Wityak J; Koder A; Vargas L; Romeo R; Mitro N; Mak PA; Seidel HM; Haslam JA; Chow D; Tuntland T; Spalding TA; Brock A; Bradley M; Castrillo A; Tontonoz P; Saez E
    J Med Chem; 2007 Aug; 50(17):4255-9. PubMed ID: 17665897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Riccardin C: a natural product that functions as a liver X receptor (LXR)alpha agonist and an LXRbeta antagonist.
    Tamehiro N; Sato Y; Suzuki T; Hashimoto T; Asakawa Y; Yokoyama S; Kawanishi T; Ohno Y; Inoue K; Nagao T; Nishimaki-Mogami T
    FEBS Lett; 2005 Oct; 579(24):5299-304. PubMed ID: 16182288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.